- Home
- PSNL vs JEQ Comparison
PSNL vs JEQ Comparison
Compare PSNL & JEQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNL
- JEQ
- Stock Information
- Founded
- PSNL 2011
- JEQ 1990
- Country
- PSNL United States
- JEQ United States
- Employees
- PSNL N/A
- JEQ N/A
- Industry
- PSNL Medical Specialities
- JEQ Air Freight/Delivery Services
- Sector
- PSNL Health Care
- JEQ Consumer Discretionary
- Exchange
- PSNL Nasdaq
- JEQ Nasdaq
- Market Cap
- PSNL 576.8M
- JEQ 99.8M
- IPO Year
- PSNL 2019
- JEQ N/A
- Fundamental
- Price
- PSNL $6.60
- JEQ $7.54
- Analyst Decision
- PSNL Strong Buy
- JEQ
- Analyst Count
- PSNL 5
- JEQ 0
- Target Price
- PSNL $8.00
- JEQ N/A
- AVG Volume (30 Days)
- PSNL 1.6M
- JEQ 32.0K
- Earning Date
- PSNL 08-06-2025
- JEQ 01-01-0001
- Dividend Yield
- PSNL N/A
- JEQ 7.05%
- EPS Growth
- PSNL N/A
- JEQ N/A
- EPS
- PSNL N/A
- JEQ N/A
- Revenue
- PSNL $85,694,000.00
- JEQ N/A
- Revenue This Year
- PSNL $0.45
- JEQ N/A
- Revenue Next Year
- PSNL $25.75
- JEQ N/A
- P/E Ratio
- PSNL N/A
- JEQ N/A
- Revenue Growth
- PSNL 15.57
- JEQ N/A
- 52 Week Low
- PSNL $1.14
- JEQ $4.99
- 52 Week High
- PSNL $7.20
- JEQ $6.39
- Technical
- Relative Strength Index (RSI)
- PSNL 69.55
- JEQ 63.20
- Support Level
- PSNL $5.88
- JEQ $6.94
- Resistance Level
- PSNL $6.72
- JEQ $7.87
- Average True Range (ATR)
- PSNL 0.44
- JEQ 0.12
- MACD
- PSNL 0.01
- JEQ -0.01
- Stochastic Oscillator
- PSNL 91.30
- JEQ 47.31
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.